Intrastromal femtosecond laser presbyopia correction successful

Article

Using the intrastromal femtosecond laser procedure to correct presbyopia has been shown to be successful.

Using the intrastromal femtosecond laser procedure to correct presbyopia has been shown to be successful, in a recent study published in the Journal of Refractive Surgery.

The prospective multicentre, nonrandomized clinical investigation, headed by Dr Mike P. Holzner, Department of Ophthalmology, International Vision Correction Research Centre, University of Heidelberg, Germany, included 63 presbyopic patients with mild hyperopia.

The procedure was performed using a femtosecond laser in the non-dominant eye and conducting near and distance visual acuity tests, slit-lamp examinations, and corneal topography. Follow-up was completed at 1 day, 1 week, and 1, 3, 6, and 12 months post-op for each patient.

Median uncorrected distance visual acuity and corrected distance visual acuity (CDVA) remained stable at 0.1 logMAR and 0.0 logMAR, respectively. Median spherical equivalent changed from +0.63 D before surgery to 0.00 D after surgery.

Preoperatively, median uncorrected near visual acuity was 0.7 logMAR but increased to 0.2 logMAR postoperatively. Eyes gained an average of 4 lines, but a loss of 2 lines of CDVA was seen in 7.1% of eyes.

The procedure demonstrated stable visual outcomes over a one year follow-up. Patient satisfaction was very high at 80%, with short treatment time and corneal surface integrity being major benefits of the procedure.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.